Search results
Results from the Health.Zone Content Network
In July 2022, The IMNF received a $13,000 grant from the Parkinson's Foundation for “Music Has Power® For Parkinson’s.” In January, 2023 research continues on modified music and synchronized light to treat Alzheimer's disease. Oscillo founder and Chief Science Officer (CSO) Edward Large, Ph.D., a professor at the University of ...
A 2017 study of 108 people with early-onset Parkinson’s found that 46.3 percent reported a family history. Drug-induced parkinsonism It occurs when a drug interferes with dopamine transmission ...
Management of Parkinson's disease. In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but ...
An amino acid called levodopa can help increase levels of dopamine in the brain. If given as a medication, it can cross the blood-brain barrier. Once in the brain, levodopa is converted to ...
The unified Parkinson's disease rating scale (UPDRS) is used to follow the longitudinal course of Parkinson's disease. The UPD rating scale is the most commonly used scale in the clinical study of Parkinson's disease. The UPDRS is made up of these sections: Part I: evaluation of mentation, behavior, and mood
Tips to slow or stop progression. Some experts suggest that you may be able to delay some of the effects of Parkinson’s disease through regular physical activity. Ideally this would include a ...
The study, published in the Journal of Neurology, Neurosurgery and Psychiatry, looked at two groups – one group of about 143 patients with Parkinson's disease and active tai chi training, and ...
Research in Parkinson's disease. The research in Parkinson's disease (also known as clinical trials, medical research, research studies, or clinical studies) refers to any study intended to help answer questions about etiology, diagnostic approaches or new treatments of Parkinson's disease (PD) by studying their effects on human subjects.